Aging-associated ependymal-cell pathologies can manifest as ventricular gliosis, ventricle enlargement, or ventricle stenosis. Ventricle stenosis and fusion of the lateral ventricle (LV) walls is associated with a massive decline of the proliferative capacities of the stem cell niche in the affected subventricular zone (SVZ) in aging mice. We examined the brains of adult C57BL/6 mice and found that ependymal cells located in the adhesions of the medial and lateral walls of the rostral LVs upregulated parvalbumin (PV) and displayed reactive phenotype, similarly to injuryreactive ependymal cells. However, PV1 ependymal cells in the LV-wall adhesions, unlike injuryreactive ones, did not express glial fibrillary acidic protein. S100B1/PV1 ependymal cells found in younger mice diminished in the LV-wall adhesions throughout aging. We found that periventricular PV-immunofluorescence showed positive correlation to the grade of LV stenosis in nonaged mice (<10-month-old), and that the extent of LV-wall adhesions and LV stenosis was significantly lower in mid-aged (>10-month-old) PV-knock out (PV-KO) mice. This suggests an involvement of PV1 ependymal cells in aging-associated ventricle stenosis. Additionally, we observed a time-shift in microglial activation in the LV-wall adhesions between age-grouped PV-KO and wild-type mice, suggesting a delay in microglial activation when PV is absent from ependymal cells. Our findings implicate that compromised ependymal cells of the adhering ependymal layers upregulate PV and display phenotype shift to "reactive" ependymal cells in aging-related ventricle stenosis; moreover, they also contribute to the progression of LV-wall fusion associated with a decline of the affected SVZ-stem cell niche in aged mice. 
cells and blood vessels. The ventricle surface in the adult neurogenic niche is organized in pinwheels with centrally located NSCs that contact the ventricle via apical processes, surrounded by ependymal cells (Mirzadeh, Merkle, Soriano-Navarro, Garcia-Verdugo, & Alvarez-Buylla, 2008) . SVZ-supported neurogenesis has been shown to considerably decrease with aging (Tropepe, Craig, Morshead, & van der Kooy, 1997) , and this decline is in part due to a reduction in epidermal growth factor receptor signaling (Enwere et al., 2004) , but other factors are likely involved, too. The morphological changes in the aging SVZ involve a reduction in the number of pinwheels, of NSCs per pinwheel, and of ventricle-containing apical processes of the NSCs (Shook, Manz, Peters, Kang, & Conover, 2012) . One unique characteristic of aging is ventral stenosis of the LV walls, which is formed by adhesion and later on fusion of the medial and lateral LV walls, causing the deterioration of the affected SVZ, therefore most of the ventral neurogenic SVZ (Luo, Daniels, Lennington, Notti, & Conover, 2006; Shook et al., 2012) . As a result of this, and/or additional age-associated alterations, the rest of the ventricular cavity expands; causing a thinning of the remaining ependymal cell layer (Conover & Shook, 2011) .
The ventricular system is lined with ependymal cells that form a cell monolayer, facilitate the circulation of cerebrospinal fluid (CSF) and participate in the metabolic exchange between CSF and brain parenchyma (Del Bigio, 2010) . Ependymal cells in the brain, unlike other epithelial linings, display inadequate regeneration following lesion since they are unable to generate progeny required for the replacement of cell loss (Spassky et al., 2005) . A form of SVZ-mediated ependyma repair throughout aging is retained by astrocytes that integrate in the ependymal layer and take on morphological features of ependymal cells (Luo, Shook, Daniels, & Conover, 2008) . Other studies revealed that in the neurogenic SVZ stem cell niche, the two main niche cell types, ependymal cells, and astrocytes retained a high level of plasticity: in response to lesion, astrocytes gave rise to ependymal cells and ependymal cells gave rise to niche astrocytes (Nomura, Goritz, Catchpole, Henkemeyer, & Frisen, 2010) . Recently, we have found an alternative mechanism of ependymal-cell response to injury: ependymocytes following mechanical lesion acquired reactive phenotype, enhanced cell motility and wound-closure capacity upon injury-induced PVupregulation (Szabolcsi & Celio, 2015) .
Ependymal-cell pathologies involve a wide variety of diseases and conditions ranging from genetic disorders resulting in hydrocephalus (Del Bigio, 2010) , declined adult neurogenesis via loss of planar cell polarity (Sawamoto et al., 2006) or ankyrin 3 (Ank3) (Paez-Gonzalez et al., 2011) , and impaired barrier function leading to leukocyte infiltration into the ventricles in infectious and inflammatory conditions (Alvarez & Teale, 2007) . Because of the restricted regenerative capacity of ependymal cells, deleterious impulses that compromise the ependymal layer often result in irreversible loss of ependymal integrity, a phenomenon that occurs throughout aging both in human and mice (Shook et al., 2013) . Aging-related ependymal cell loss implies ventricular surface gliosis and consequent ventricle enlargement-a condition often observed in elderly humans (Shook et al., 2013) , revealing the importance of maintaining an intact ependymal cell lining throughout aging.
During the course of ventricle stenosis, the ependymal layer is essentially intact in the adhered LV walls in 3-month-old mice, but deteriorates throughout aging as fusion progresses, leaving 1-year-old mice without ependymal cells in the fused regions (Shook et al., 2012) .
Most importantly, SVZ-supported neurogenesis is also absent in fused LV walls lacking ependymal cells, thereby extensive LV-wall fusions contribute fundamentally to the aging-related decline of SVZ-supported neurogenesis (Shook et al., 2012) . Despite its impact, the molecular and cellular players underlying the progression of LV-wall fusion are so far unknown.
This study was undertaken to learn more about the role ependymal cells play in the progression of aging-related LV-wall fusion and ventricle stenosis and to determine what role ependymal PV-expression might play in this process. PV-KO-eGFP mice were generated by crossing a PV-eGFP mouse strain (B6.Tg(Pvalb-EGFP)1Hmon) to a PV-KO one (B6.Pvalbtm1S-walXB6Tg(Pvalb-EGFP)1Hmon) (Schwaller et al., 1999) . Foxj1-eGFP mice [(B6;C3-Tg(FOXJ1-EGFP)85Leo/J, Jackson Laboratory, Sacramento, CA] express eGFP under the control of the human forkhead box J1 (Foxj1) gene promoter, a transcription factor known as the master regulator of motile ciliogenesis (Ostrowski, Hutchins, Zakel, & O'Neal, 2003) . In the murine brain, Foxj1-expression is restricted to ependymal cells and a subset of astrocytes in the adult stem cell niche in the SVZ (Jacquet et al., 2009 ). All animal experiments were performed according to institutional guidelines and with the permission of the cantonal committee on animal experimentation (Permission No: 2016_03_FR).
| Immunofluorescence
40-mm-thick coronal sections with a freezing microtome (Frigomobil, Reichert-Jung, Vienna, Austria). Immunofluorescence was performed on free-floating sections with the following antibodies and antisera (Table 1) : rabbit anti-PV (diluted 1:1,000, Swant, Marly, Switzerland, Cat. #PV 25, RRID:AB_10000344), guinea pig anti-PV (diluted 1:1,000, Swant, Marly, Switzerland, Cat. #GP72, RRID:AB_2665495), rabbit anti-S100B (diluted 1:1,000, Swant, Marly, Switzerland, Cat. #37, RRID:AB_2315304), guinea pig anti-S100B (diluted 1:500, Synaptic Systems, G€ ottingen, Germany, Cat. #287 004, RRID:AB_2620025), mouse anti-glial fibrillary acidic protein (GFAP) (diluted 1 mg/ml, Novus Biologicals, Cambridge, UK, Cat. #NBP1-05197, RRID:AB_1555288), rabbit anti-GFP (diluted 1 mg/ml, Molecular Probes, Thermo Fisher Scientific, Reinach, Switzerland, Cat. #A-11122, RRID:AB_221569), mouse anti-GFP (diluted 0.1 mg/ml, Molecular Probes, Thermo Fisher Scientific, Reinach, Switzerland, Cat. #A-11120, RRID:AB_221568), and rabbit anti-Iba1 (diluted 1 mg/ml, Wako, Neuss, Germany, Cat. #019-19741, RRID:AB_839504). Primary antibodies were diluted in 0.1M TBS pH 7.3 with 0.1% Triton X-100 and 10% bovine serum and incubated overnight at 48C. Primary antibody staining was revealed using species-specific fluorophore-conjugated secondary antibodies (Cy3, 
| Characterization of the antibodies and antisera
We confirmed the specificity of the antibodies and antisera used in this study by Western blotting. Brains from adult C57Bl/6 and PV-KO and muscle tissue from PV-eGFP euthanized mice were quickly removed, homogenized and soluble proteins were extracted for Western blotting experiments. Proteins (50 mg for brain and muscle lysates) were separated by sodium dodecyl suflate polyacrylamid geleletrophoresis (SDS-PAGE) (12%). After electrophoresis, the proteins were transferred on nitrocellulose membranes (MS solution, Chemie Brunschwig, Basel, Switzerland). The membranes were then blocked in 5% nonfat milk in TBS-T for 20 min at room temperature and incubated with primary antibodies as listed in Table 1 Analytica, Rheinfelden, Switzerland) in TBS-T. Finally, membranes were repeatedly rinsed in TBS and developed using enhanced chemiluminescence (ECL) (Merck Millipore, Schaffhausen, Switzerland). Bands were visualized using FluorChem E (San Jose, CA). Additionally, we confirmed the staining patterns of each antibody and antiserum (Table 1) on coronal brain sections throughout the whole brain by immunofluorescence as described above.
The polyclonal guinea pig PV antiserum was raised against recombinant mouse PV. The polyclonal rabbit PV antiserum was raised against recombinant rat PV. In Western blot, a single band at the molecular weight level of PV (12 kDa) was detected by both rabbit n 5 3 for GP72) was determined by calculating the ratio of the intensity of the signal for PV to that of the normalization control. Both the rabbit and guinea pig anti-PV antibodies showed similar affinity for the target protein (8.04% 6 3.8 for GP72 and 7.6% 6 3 for PV 25, p 5 .885).
Additionally, we calculated the ratios of the intensity of the signal for the recombinant protein. Both anti-PV antibodies showed similar affinity for the pure recombinant PV protein. We also confirmed by immunofluorescence that the staining patterns of both anti-PV antibodies were identical in different brain areas regarding cellular morphology and distribution and consistent with that of PV-interneurons ( Figure   1a ,b) as demonstrated previously (Filice, Vorckel, Sungur, Wohr, & Schwaller, 2016; Xu, Roby, & Callaway, 2010) . These results confirm the specificity of the anti-PV antibodies.
The monoclonal anti-GFAP antibody was raised against purified pig spinal cord GFAP. We tested the antibody by immunofluorescence on murine coronal brain sections and confirmed that the pattern of staining regarding cellular morphology and distribution in the brain was consistent with that of astrocytes (Figure 1c ) as demonstrated in previous studies (Sofroniew & Vinters, 2010) . This antibody was shown to label astrocytes in previous studies as well (Brai et al., 2014; Szabolcsi & Celio, 2015) . In Western blot, the antibody detected a single band at about 50 kDa-corresponding to the major isoform of GFAP-in murine brain protein extract (Figure 1f ), whereas no signal was detected in muscle protein extract (negative control).
The polyclonal rabbit S100B antiserum was raised against purified bovine brain S100B. We confirmed that the staining pattern throughout the brain regarding cellular morphology and distribution corresponds to astrocytes and ependymal cells (Figure 1d ) as demonstrated in previous studies (Raponi et al., 2007; Spassky et al., 2005) . In Western blot, the antiserum detected a prominent band at about 10 kDacorresponding to the expected molecular weight of S100B-in mouse brain protein extract, whereas no signal was detected in muscle protein extract (Figure 1g ). The S100B antiserum was used to label ependymal cells in murine brain sections and organotypic slice cultures in our previous study (Szabolcsi & Celio, 2015) . Previous studies showed that in Western blot analysis of gerbil brain lysate, the S100B antiserum recognized the expected band at about 10 kDa (Ford, Grothe, & Klug, 2009 ).
The polyclonal guinea pig S100B antiserum was raised against recombinant full length rat S100B. We tested the specificity of the antiserum by comparing the staining pattern with that of the polyclonal rabbit S100B antiserum on coronal murine brain sections throughout the entire brain. We confirmed that the staining patterns were identical (Figure 1d) . In Western blot, the antiserum detected a prominent band at the expected molecular weight 10 kDa in murine brain protein extract, while no signal was detected in muscle protein extract ( Figure 1h ).
The purified polyclonal rabbit Iba1 antiserum was raised against a synthetic peptide corresponding to the C-terminus of Iba1. We confirmed by immunofluorescence that the staining pattern of the Iba1 antiserum in the brain regarding cell morphology and distribution is consistent with that of microglial cells (Figure 1e ) as demonstrated in previous studies (Ito et al., 1998) . In Western blot, the antiserum detected the expected band at about 17 kDa corresponding to the molecular weight of Iba1 ( Figure 1i ). This Iba1 antibody was shown to label murine microglial cells in previous studies as well (Bosco, Steele, & Vetter, 2011; Petkau et al., 2010) .
The polyclonal rabbit GFP antiserum was raised against GFP protein isolated from the jellyfish Aequorea victoria. We previously confirmed the immunofluorescence specificity by comparing the staining pattern with the eGFP-expression pattern in Foxj1-eGFP and PV-KOeGFP organotypic hippocampal slice cultures (Szabolcsi & Celio, 2015) .
In Western blot, the antibody detected a single band at about 30 kDa in PV-eGFP muscle protein extract corresponding to the expected molecular weight of GFP, while no signal was detected in the WT brain
Characterization of the antibodies and antisera. We confirmed the specificity of the antibodies and antisera used in this study by Western blotting, respectively by analyzing the immunofluorescence staining patterns. Confocal z-stack overprojections in the regions of the cingulate cortex and reticular thalamic nucleus (RTN) depict PV-immunopositive neurons stained with rabbit anti-PV (PV 25, Swant) (a) and with guinea pig anti-PV (GP72, Swant) (b) antibodies. The staining patterns of the two anti-PV antibodies are comparable. Whole brain protein extracts from adult C57Bl/6 and PV-KO mice were separated by SDS-PAGE and transferred on nitrocellulose membranes. After blocking, the membranes were incubated with rabbit anti-PV (a) and guinea pig anti-PV (b) antibodies. Pure recombinant calretinin (CR) and calbindin (CB) proteins were used as additional negative controls, and pure recombinant parvalbumin (PV) protein as positive control. A single band at the expected molecular weight of PV (12 kDa) was detected by both antibodies in brain extracts form wild-type (WT) animals, while no signal was detected in extracts from PV-KO mice (a, b). Pure recombinant PV tends to form dimers in solution, which were also detected by both antibodies at about 24 kDa in addition to the expected 12 kDa signal (a, b). Confocal z-stack overprojections depict GFAP-immunostained astrocytes in the corpus callosum, hippocampus and internal capsule (c), S100B-immunostained astrocytes in the cingulate cortex and striatum, respectively ependymal cells in the lateral ventricle (LV) walls (d), and Iba1-immunostained microglia in the cingulate cortex, striatum, and internal capsule (e). Coronal sections incubated with secondary antibodies without previous incubation with primary antibodies were used as negative controls. The staining pattern of the mouse anti-GFAP antibody (Novus Biologicals) is consistent with that of astrocytes (c). The rabbit anti-S100B (Swant) and the guinea pig anti-S100B (Synaptic Systems) staining patterns appear comparable (d). The Iba1-immunostaining pattern is consistent with that of microglia (e). In Western blot analysis, the mouse anti-GFAP detects the expected band at about 50 kDa in the murine brain and gives no signal in the muscle protein extract (f). The rabbit anti-S100B detects a prominent band at about 10 kDa in the murine brain protein extract, while no signal is detected in muscle protein extract (g). Similarly, the guinea pig anti-S100B detects a prominent band at about 10 kDa in the murine brain protein extract, and no signal in the muscle protein extract (h). The anti-Iba1 detects the expected band at about 17 kDa in the murine brain lysate, with no signal detected in the muscle extract (i). Both the rabbit anti-GFP (j) and mouse anti-GFP (k) antibodies recognize the expected band about 30 kDa in the PV-eGFP muscle protein extract, while they detect no signal in the WT brain protein extracts. GP 5 guinea pig; Ms 5 mouse; Rb 5 rabbit protein extract (Figure 1j ). In previous studies, the antibody was shown to detect a single band in Western blot analysis of whole-cell lysates from GFP-transfected normal human epidermal keratinocytes (NHEK) cells, and was negative in untransfected cells (Hiroyasu et al., 2013) .
The monoclonal anti-GFP antibody was raised against GFP protein isolated from the jellyfish A. victoria. We tested the immunofluorescence specificity by confirming that the staining pattern coincided with the eGFP-expression in Foxj1-eGFP, respectively in PV-KO-eGFP organotypic hippocampal slice cultures (Szabolcsi & Celio, 2015) and in coronal brain sections derived from Glycine transporter 2 (GlyT2)-eGFP mice (Szabolcsi, Albisetti, & Celio, 2017) . In Western blot, the antibody detected a single band at about 30 kDa in PV-eGFP muscle protein extract corresponding to the expected molecular weight, while no signal was detected in the WT brain protein extract (Figure 1k ). Image post-processing was limited to contrast adjustment only and was done by ImageJ.
| Image acquisition by confocal microscopy
The Leica TCS SP5 confocal laser scanning microscope system used for fluorescence intensity measurement was equipped with an inverted Nonaged (4-month-old) C57BL/6 mice exhibit unilateral ventricle stenosis and PV-immunopositive ependymal cells in the adhering ependymal layers. Confocal laser z-stack overprojections depict the nonadhering LV walls (a) and the adhering ones on the contralateral side (b). Immunofluorescence for S100B revealed a uniform staining of the ependymal layers in the nonadhering LV walls (a), whereas a continuous S100B-stained ependyma was lacking in the LV-wall adhesion (b). Instead, patches of S100B-positive ependymal cells could be observed in the adhesion zone (b, arrows). PV-immunostaining was found in S100B-immunopositive ependymal cells (d), whereas it was virtually absent from the normal, nonadhering LV walls (c). Approximately 5-mm-thick thin layer reconstruction of few z-planes shows coexpression of S100B and PV-immunofluorescence in the same cells in the LV-wall adhesions (d1). GFAP-immunostaining on the same sections revealed several GFAP-stained astrocytic processes intermingled in the PV1 ependymal-cell clusters of the LV-wall adhesions (f), as well as in the normal, nonadhering ependymal layer on the contralateral side (e). In thin layer reconstruction of few z-planes, no co-labeling between GFAP-and PV-staining was observed (f1). We examined the LV walls of 8-month-old Foxj1-eGFP mice, which display transgenic eGFP-expression in ependymal cells. Confocal z-stack overprojections of nonadhering LV walls depict eGFP-stained ependymal layers with virtually absent PV-immunoreactivity (g, g1), whereas adhered LV walls display Foxj1-eGFP1/PV1 cell islands (h). Thin layer reconstruction of few z-planes (approximately 4 mm thick) demonstrates that PV and eGFP are co-expressed in the same cells (h1). Confocal z-stack maximum overprojection of GFAP-immunostaining shows GFAP-immunopositive processes infiltrated in the adhesion site, with no coexpression of GFAP and Confocal laser z-stack overprojection of 8-month-old Foxj1-eGFP mice depicts eGFP1/PV1 cells in the LV-wall adhesion (e-h, adhered LV walls marked by dashed lines), magnified thin layer reconstruction image is shown in (h1). Some of the PV-expressing ependymal cells possess elongated cellular processes that extend into the adhesion (c, g, arrows) . This cell morphology suggests a reactive phenotype, and resembles that observed in reactive postinjury ependymal cells (i-k). Unilateral in vivo stab-wound (marked by a dashed line) over the cortex and LV wall was performed in Foxj1-eGFP mice (i). One week following lesion, GFAP-immunostaining depicts reactive astrocytes around the stab-wound in the parenchyma, while GFP-staining reveals a lesioned, interrupted ependymal layer (i). Confocal z-stack overprojections of the ependymal layer adjacent to the stab-wound injury display several reactive eGFP1 cells with long basal processes extending into the parenchyma, approximately perpendicularly to the ependymal layer (j, k, arrows). Some of these Foxj1-eGFP1 ependymal cell processes co-express PV, as shown in thin layer (of approximately 3 mm thickness) reconstruction image in (j1). Cell morphological features seen in (j) and (k) are similar to those of PV-immunopositive ependymal cells found in the LV-wall adhesions (a-h). inj. 5 stab-wound injury; LV 5 lateral ventricle offset, etc.) were set to maximize signal-to-noise ratio and to avoid over-or underexposure throughout the entire z-volume of the samples, following well-established guidelines (Waters, 2009 graduations which can be assigned to a pixel (pixel intensity 0 corresponding to no signal, while 255 to maximal signal). Therefore, a threshold range was set to tell the objects of interest apart from the background by the "Adjust threshold" command in ImageJ. After testing several thresholding settings, we defined the optimal threshold to be 70-255 for the entire image sequence, thus excluding the analysis of all the pixels whose intensity value was below 70. We then subjected the image sequence to the "Analyze particles" plugin, by applying no particle size filter or circularity filter. Area, mean, minimal and maximal gray value, standard deviation, area fraction, and integrated were processed for confocal imaging as described above, followed by the fluorescence intensity measurement workflow described here.
In another set of experiments, Iba1-immunostained coronal sections of WT (n 5 6) and PV-KO (n 5 6) mice of different ages ranging from 6-to 15-month-old were imaged by a Leica DM 6000B fluorescent microscope. In the regions encompassing the LV wall adhesions, at least four 40-mm-thick-sections-spaced 160 mm from each other-per mouse were imaged, maintaining the same settings of image acquisition for all the animals. Several ROIs with an area of 268.57 mm 3 307.62 mm were defined in the images; in the regions of the LV-wall adhesions and in the striatum adjacent to the LV walls in the same section serving as control Iba1-staining. All the images were added into a single image sequence, which was subjected to the fluorescence intensity measurement workflow described above. We defined the optimal threshold to be 50-255 for the entire image sequence, and subjected it to the "Analyze particles" plugin applying a particle size filter 15 mm 
| Statistics
To compare the data sets, statistical strength was analyzed by GraphPad Prism 7 (RRID:SCR_002798) using ordinary one-way ANOVA with In young adult (4-month-old) C57BL/6 mice (n 5 5), we found the lateral and medial walls of the rostral portion of the LV to adhere to each other, resulting in unilateral or bilateral ventricle stenosis. We observed that the nonadhering LV walls displayed an uninterrupted, healthy ependymal layer visualized by the ependymal-cell marker S100B with virtually absent PV-expression (Figure 2a,c) . However, in the regions of LV-wall adhesion, the ventricle walls partially lacked an intact ependymal layer (Figure 2b ). Instead, patches of S100B-stained ependymalcell islands could be observed in the adhesions (Figure 2b , arrows), which also displayed PV-immunoreactivity in addition to S100B-expression ( Figure 2d ). We also examined the single z-planes of the confocal z-stacks for co-expression, and we found S100B1/PV1 cells in the adhered LV walls (Figure 2d1 , thin layer reconstruction). Large portions of the adhered LV walls were devoid of an S100B1 ependymal layer, which is in line with previous observations that described the loss of ependymal cells in the LV-wall fusions in aging mice (Shook et al., 2012) . We also examined if ependymal cells in LV-wall adhesions co-expressed the astrocyte marker GFAP, similarly to reactive ependymal cells following mechanical injury (Szabolcsi & Celio, 2015) and stroke (Young et al., 2013) . We found GFAP-immunopositive processes to infiltrate the adhesion site and to intermingle with the PV1 cells ( Figure 2f) ; however, upon examination of single confocal z-planes throughout the adhesion site and thin layer reconstructions, we did not detect co-expression of GFAP and PV in the same cells (Figure 2f1 ).
The nonadhering LV walls also displayed numerous strongly stained GFAP-positive processes in the ependymal layer (Figure 2e ). The dense periventricular GFAP-immunostained astrocytic processes reflect ventricular astrogliosis (hereafter: ventricular gliosis) which is associated with ventriculomegaly in the human and murine brain (Shook et al., 2013) . By visual observation, ventricular gliosis represented by GFAPimmunostaining did not appear to be more pronounced in the LV-wall adhesion site than in the nonadhered LVs (Figure 2e ,f).
Given that S100B labels astrocytes in addition to ependymal cells (Cocchia, 1981) , we used an additional approach to ascertain that PV- 
| PV-expressing ependymal cells in LV-wall adhesions acquire a reactive phenotype
When we examined the morphology of PV-stained ependymal cells of the LV-wall adhesions (Figure 3a-d) , we observed elongated, bipolar cell shape with long, thin cellular processes (Figure 3c , arrows), which co-expressed the ependymal-cell marker S100B (Figure 3d ). We observed similar cell morphology when we analyzed the LV-wall adhesions of Foxj1-eGFP mice (Figure 3e-h (Figure 4d ). Therefore, we used mice of both sexes throughout the study.
3.4 | PV-immunofluorescence intensity in the LV walls correlates to the adhesion volume but not to the LV volume in <10-month-old mice, whereas periventricular GFAP-immunofluorescence intensity shows no correlation On the other hand, ventricular gliosis reflected by periventricular GFAP-staining seems to be unrelated to the extent of LV-wall adhesion and ventricle stenosis grade in all the examined age groups. This is in line with the observation that ventricular gliosis is associated with ventriculomegaly, whereas no such link to ventricle stenosis has been described (Shook et al., 2013) . Based on these results, we presume that the early presence of PV1 ependymal cells and not ventricular gliosis is associated with the formation of LV-wall fusions, which then leads to ventricle stenosis and SVZ-decline throughout aging.
3.5 | S100B1/PV1 ependymal cells diminish in LVwall adhesions in aging mice, whereas periventricular gliosis changes spatial distribution
Based on these results, we raised the question whether PVimmunoreactivity in LV-wall adhesion ependymal cells declines in older mice. Therefore, we analyzed the LVs of 4-month-old (n 5 3), 8-monthold (n 5 5), and 15-month-old (n 5 3) WT mice. Co-immunostaining for S100B, GFAP and PV showed S100B1/PV1 ependymal cell clusters in the LV-wall adhesions of 4-month-old (Figure 6a , arrows) and 8-FIG URE 5 Periventricular PV-immunofluorescence is positively correlated to LV-wall adhesion volume and not to LV volume in mice younger than 10-month-old, whereas no correlation applies for periventricular GFAP-immunofluorescence. Periventricular PV-and GFAPimmunofluorescence intensity was quantified in confocal z-stack overprojection images of coronal sections of C57BL/6 mice (aged between 6 and 15 months, n 5 8) upon excluding regions outside the periventricular area. Following threshold adjustment and particle analysis by ImageJ, the integrated density (IntDen, product of area and mean gray value) of PV-and GFAP-immunofluorescence images was calculated and averaged following subtraction of the IntDen values of the negative controls. The mean IntDen was plotted relative to the adhesion volume and to the LV volume. In nonaged mice (<10-month-old, n 5 5), PV-immunofluorescence showed positive linear correlation to the adhesion volume (R 2 5 0.4516, p 5 .0474, one outlier removed) (a). No significant correlation applied between PV-immunofluorescence and LV volume (b), or between GFAP-immunofluorescence and adhesion volume (c), respectively LV volume (d). In older mice (>10 month-old, n 5 3), none of the above-mentioned parameters were found to be correlated month-old (Figure 6b , arrows) mice, whereas such ependymal-cell populations were almost entirely lacking in 15-month-old mice (Figure 6c ). This is in line with the observations that PV-staining intensity in the LV-wall adhesions correlates with adhesion volume-reflecting adhesion extent-in mice aged less than 10-month-old, but not in mice over 10 month of age, respectively with previous works that reported the disappearance of S100B1 ependymal cells from the LV-wall adhesions in 1-year-old mice (Shook et al., 2012) .
GFAP-positive processes reflecting astrocytes could be found along the entire length of the LV-wall adhesions in 4-month-old mice (Figure 6a , arrowheads), whereas in 8-and 15-month-old mice GFAP1 astrocyte processes were found to be concentrated mostly FIG URE 6 With aging, S100B1/PV1 ependymal cells decline in the LV-wall adhesions, whereas the distribution of ventricular gliosis undergoes spatial transposition. Confocal laser z-stack overprojection images of coronal sections from 4-month-old (a), 8-month-old (b), and 15-month-old (c) mice encompassing the regions of LV-wall adhesions (delineated by dashed lines) were immunostained for PV, S100B, and GFAP. Patches of S100B1/PV1 ependymal cells can be observed along the adhered ventricle walls in 4-month-old (a, arrows), respectively in 8-month-old mice (b, arrows). In 15-month-old mice, S100B1/PV1 cells are almost entirely lacking from the LV-wall adhesion zone (c). GFAP-immunostaining can be observed along the entire length of the adhering LV walls in 4-month-old mice (a, arrowheads). In 8-month-old mice, GFAP-stained processes are confined to the close vicinity of the LV (b, arrowheads), whereas it is largely lacking in the LVwall adhesions. Similar is the situation in 15-month-old mice (c, arrowheads)
around the ventricle-contacting areas of the LV-wall adhesions (Figure 6b,c, arrowheads) . These findings suggest that LV-wall adhesions display some degree of gliosis along the adhering LV walls in early stages of ventricle stenosis, whereas later on periventricular gliosis is transposed to the surroundings of the ependymal layer that contacts the ventricle, and diminishes in the fused LV walls which lost ventricular contact.
3.6 | LV-wall adhesions of PV-KO-eGFP mice display crucial morphological alterations throughout aging
Next, we raised the question if PV-expressing ependymal cells in LVwall adhesions contribute significantly to the progression of LV-wall fusions seen in aged mice. We found by visual observation that older PV-KO mice exhibited a reduced grade of ventricle stenosis than that of WT mice (Figure 7a,b) . We also examined the LVs of PV-Cre/eGFP FIG URE 7 LV-wall adhesions of PV-KO-eGFP mice display crucial morphological alterations throughout aging. Low magnification image of a DAPI-counterstained coronal section at the level of the rostral portion of the LV reveals severe unilateral ventricle stenosis in a 13-month-old WT C57BL/6 mouse (a), whereas the LVs at approximately the same level display no adhesions in an 11-month-old PV-KO mouse (b). Confocal laser z-stack overprojection image of coronal sections encompassing the LV-wall adhesion region displays adhering LV walls with eGFP1 ependymal cells in the adhered ependymal layers in 6-month-old (c) and 14-month-old PV-Cre/eGFP (e) mice. Periventricular GFAP-immunopositive astrocyte processes can be found along the adhering ventricle walls (c, e), whereas eGFP1 cells are numerous in the LV-adhesion of 6-month-old (c, arrowheads) but virtually absent in the 14-month-old (e) PV-Cre/eGFP mouse. Confocal laser zstack overprojection image in a 6-month-old PV-KO-eGFP mouse also demonstrates adhesions between the LV walls, with intensive GFAP (d, arrows) and S100B-immunostaining (d1) along the adhering ependymal layers. Several eGFP1 cells are present in the ependymal layers (d, arrowheads). Thin layer reconstruction of approx. 5 mm thickness depicts the S100B-positive ependymal layer to co-express GFAP (d2). Eleven-month-old PV-KO-eGFP mice display nonadhering LV walls with numerous eGFP1 cells in the ependymal layers (f, arrowheads). S100B-staining appears mostly intact in the 11-month-old PV-KO-eGFP mouse (f1), whereas some GFAP-stained patches can be found along the LV-wall thickenings (f, arrows). Thin layer z-reconstruction of S100B-and GFAP-immunostaining is shown in (f2) (n 5 6) and PV-KO-eGFP (n 5 5) mice of different ages. When we compared nonaged (6-month-old) PV-KO-eGFP and PV-Cre/eGFP mice, we often found adhering medial and lateral LV walls in PV-KO-eGFP mice ( Figure 7d ); similarly to PV-Cre/eGFP ones of the same age (Figure 7c) . In 6-month-old PV-KO-eGFP, numerous eGFP1 cells were present in the adhering ependymal layers ( Figure 7d, arrowheads) ; moreover, the LV walls displayed extensive GFAP-immunostaining (Figure 7d, arrows) . The LV walls also retained an intact S100B-staining, 3.7 | Mid-aged PV-KO mice (10-15-month-old) has significantly reduced ventricle stenosis grade when compared to their WT counterparts Next, we quantified and compared the adhesion volume and the LV volume in adult (6-15-month-old) WT C57BL/6 (n 5 13) and PV-KO (n 5 18) mice. We found that younger mice (6-9 month old) displayed no significant differences in adhesion volume [8,818,400 3.8 | Microglial activation was observed in both PV-KO and WT LV-wall adhesions, with a delay in PV-KO mice
We postulated that at some point during the progression of fusion between medial and lateral LV walls microglial activation was implicated, since microglial cells were previously shown to exhibit robust activation, phagocytosis of ependymal debris and migration upon FIG URE 9 Microglia is activated in the LV-wall adhesion in both WT and PV-KO mice, however, at different extent between age groups. Fluorescent micrographs displaying Iba1-immunostaining on coronal sections-at the level of LV-wall adhesions-of age-grouped PV-KO and WT C57BL/6 mice show visibly more enhanced Iba1-immunofluorescence in the adhesion zone (marked by dashed lines) than in the control region of the striatum in each of the presented age groups and genotypes (a). Iba1-immunofluorescence intensity (integrated densityIntDen) was quantified on a series of ROIs in the control, respectively adhesion regions following threshold adjustment and particle analysis by ImageJ. In the graph, IntDen is displayed as mean IntDen values following averaging (b). Significant increase of Iba1-immunofluorescence is seen in the LV-adhesions of each group when compared to the control region (b (Carbonell, Murase, Horwitz, & Mandell, 2005) .
The increased expression level of the microglia marker Iba1 was shown to be associated with microglial activation (Ito, Tanaka, Suzuki, Dembo, & Fukuuchi, 2001) , therefore, we quantified Iba1-immunoreactivity in adult PV-KO and WT mice in the LV-wall adhesions and in the striatum as control in the different age groups (Figure 9a ). Iba1-immunofluorescence-measured as integrated density (IntDen) by ImageJ upon threshold adjustment in defined ROIs (268.57 mm 3 307.62 mm)-of the LV-wall adhesions was compared to the control Iba1-staining in the striatum on the same sections. We found a significant increase of Iba1-immunoreactivity in the LV-adhesions in both younger (6-9 month-old) and older (10-15 month-old) WT and PV-KO mice (Figure 9b ). The degree of increase was however somewhat different between the age groups: 6-9 month-old WT mice displayed a 
| DISCUSSION
We found PV-immunopositive ependymal cells in the adhered layers of the rostral LV walls of nonaged WT mice, which co-expressed the ependymal cell marker S100B and displayed a reactive phenotype similar to injury-reactive ependymal cells described in our previous study (Szabolcsi & Celio, 2015) . The aim of our study was to investigate the relevance of PV-positive ependymal cells in LV-wall adhesions. We found that periventricular PV-immunoreactivity correlated to the grade of LV stenosis in mice younger than 10 month of age. In line with this observation, we found significantly lower grade of ventricle stenosis in older PV-KO mice, suggesting that PV-expressing ependymal cells contribute to the early stages of the formation of LV-wall fusions, and consequently to the progression of LV stenosis. We observed that throughout aging, as adhesion/fusion of the LV walls progresses, PVexpressing ependymal cells diminished from the LV-wall fusions. We quantified the grade of ventricle stenosis of PV-KO and C57BL/6 WT mice, and found significantly lower adhesion extent and stenosis grade in mid-aged (>10-month-old) PV-KO mice when compared to their WT counterparts, whereas no difference was found between younger (<10-month-old) PV-KO and WT mice. Thus, our findings highlight an important involvement of PV-expressing ependymal cells found in adhering LV walls in the aging-associated progression of ventricle stenosis.
During the course of ventricle stenosis, mice develop fusions of the medial and lateral LV walls with a resulting deterioration of the initially intact ependymal layer and most importantly, a decline of the functional proliferative zone in the affected SVZ in the regions of the LV-wall fusions (Luo et al., 2006; Shook et al., 2012) . Ependymal cells lining brain ventricles display only limited regenerative capacities since they are fully differentiated (Spassky et al., 2005) , and they have been shown to irreversibly disappear from the ventricle wall adhesions throughout aging (Shook et al., 2012) . Nevertheless, the rate of production and absorption of CSF might also alter the brain ventricle volume, potentially leading to ventriculomegaly or ventricle stenosis. Alterations in the microarchitecture of the SVZ might also contribute to events that compromise the barrier integrity.
Ependymal-cell responses to these factors might be very variable.
Mature ependymal cells in the brain do not reenter the cell cycle under normal conditions; however, they have been shown to generate new neurons and glial cells upon disruption of Notch signaling (Carlen et al., 2009 ). Nevertheless, they fail the "stemness" criteria due to their incapability of self-renewal. Thus, their primary role in the brain seems to lay in providing an important barrier between CSF and brain parenchyma. We have recently described the injury-induced PVupregulation in ependymal cells, which displayed reactive phenotype, enhanced cell motility and wound-closure capacity upon PVexpression (Szabolcsi & Celio, 2015) . We showed that such PVexpression in ependymal cells was NF-ƘB signaling dependent and could be modulated by altering the level of oxidative stress, thus implicating injury-induced inflammation in this process. We also found previously that injury-reactive ependymal cells acquired a reactive phenotype, which resembles that of ependymal cells in the LV-wall adhesions described in our present study. This suggests that ependy- Why do ependymal cells upregulate PV? PV is an EF-hand calcium-binding protein known as a slow-onset calcium buffer with high calcium-binding affinity. PV is abundantly expressed in the brain, mostly in fast-spiking GABAergic interneurons (Celio, 1986) but also in long projection neurons (Bilella, Alvarez-Bolado, & Celio, 2016) , where its role is extensively studied, however, very little is known about PV in other elements of the nervous system. Calcium buffers such as PV are believed to alter the spatiotemporal aspects of calcium transients (Schwaller, Meyer, & Schiffmann, 2002) . Some calcium-signaling related mechanisms could also be involved in the case of reactive phenotype shift seen in ependymal cells, however, the spectrum of biological processes that are dependent on calcium-signaling are endless. The cell shape alterations seen in LV-wall adhesion ependymal cells are similar to those seen in injury-reactive ependymal cells (Szabolcsi & Celio, 2015) , therefore, we could assume that PV-upregulation implies similar processes in the case of LV-wall adhesion ependymal cells as well, such as cytoskeletal remodeling and cell motility. However, the precise molecular pathways where PV could interact are yet to be discovered.
In our present study, we demonstrate for the first time an ependymal-cell response triggered by the fusion of the opposite LV walls that involves PV-upregulation and reactive phenotype shift in ependymal cells in the affected regions. PV-positive ependymal cells seem to contribute to the propagation of adhesion-and fusionformation observed throughout aging, based on our observation of lower ventricle stenosis grade in aging PV-KO mice. The development of ventricle stenosis associated to severe decline in adult neurogenesis throughout aging is poorly understood, our study therefore sheds light on a novel aspect of this biological feature of aging.
